Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07315191) titled 'Finerenone Therapy for Pediatric HSPN With Mild Proteinuria' on Dec. 18, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Capital Institute of Pediatrics, China

Condition: Children of HSPN With Mild Proteinuria

Intervention: Drug: ACEI / ARB+finerenone

Recruitment Status: Recruiting

Phase: Phase 4

Date of First Enrollment: June 13, 2025

Target Sample Size: 116

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07315191

Published b...